The Company has informed the Exchange regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP.
Press Release Jan 27 2026
Earlier from Caplin Point Laboratories
- Press Release Oct 23 2025
- Press Release Sep 03 2025
- Press Release May 14 2025
- Press Release Apr 23 2025
